Sign In

CPG Infobase: Clinical Practice Guidelines


The CPG Infobase is a database of evidence-based Canadian clinical practice guidelines (CPGs). Maintained by Joule, a CMA company, it includes approximately 1,200 CPGs developed or endorsed by authoritative medical or health organizations in Canada.

CMA members access CPG Infobase through Joule on cma.ca. In late 2018, this tool—with some additional features—will make the move to a new home on joulecma.ca. Although we anticipate a seamless experience, if you experience any interruption in service, please contact memberservicecentre@cma.ca/Tel: 888-855-2555 (toll-free).

List of Guidelines

For Subject: Drug Prescriptions
Number of CPGs:  28

  • Results 1-10
1.
Médecament antibiotiques - antibioprophylaxie lors des chirurgies orthopédiques propres chez l’enfant et l’adulte

View PDF
2018-juin
Institut national d’excellence en santé et en services sociaux

Detailed Result

2.
Médecament antibiotiques - blépharite

View PDF
2018-juin
Institut national d’excellence en santé et en services sociaux

Detailed Result

3.
Médecament antiviraux - atteintes oculaires à herpès simplex

View PDF
2018-juin
Institut national d’excellence en santé et en services sociaux

Detailed Result

4.
Médecament antiviraux - zona ophtalmique

View PDF
2018-juin
Institut national d’excellence en santé et en services sociaux

Detailed Result

5.
Deprescribing benzodiazepine receptor agonists

View PDF
2018-May
Deprescribing Benzodiazepine Guideline Development Team

Detailed Result

6.
Déprescription des agonistes des récepteurs des benzodiazépines

View PDF
2018-mai
Deprescribing Benzodiazepine Guideline Development Team

Detailed Result

7.
Lignes directrices simplifiées en matière de prescription de cannabinoïdes médicaux en soins de première ligne

View PDF
2018-fév
Comité des lignes directrices en matière de prescription de cannabinoïdes médicaux

Detailed Result

8.
Simplified guideline for prescribing medical cannabinoids in primary care

View PDF
2018-Feb
Medical Cannabinoids Prescribing Guideline Committee

Detailed Result

9.
Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia

View PDF
2018-Jan
Deprescribing Antipsychotics Guideline Development Team

Detailed Result

10.
Déprescription des antipsychotiques pour les symptômes comportementaux et psychologiques de la démence et l’insomnie

View PDF
2018-janv
Deprescribing Antipsychotics Guideline Development Team

Detailed Result



Disclaimer:
All content is provided for information and education and not as a substitute for the advice of a physician. Joule assumes no responsibility or liability arising from any error or omission or from the use of any information contained herein.